Antimicrobial stewardship leads from inpatient point prevalence surveillance of a tertiary-level care hospital

ABSTRACT

Background: To explore the scope of antimicrobial stewardship activities based on the point prevalence study of antimicrobials among hospitalized patients in a tertiary-level care hospital in the UAE. Methods: A single-center cross-sectional prevalence study was conducted among inpatients admitted to a tertiary care hospital using the European Surveillance of Antimicrobial Consumption tool in February 2023. Antimicrobials used against bacteria only were surveyed. All patients admitted to the selected departments at 8 AM on the day of the survey were included. Data were described in numbers and percentages. Results: Among 136 patients admitted at the time of the study, 87 received antimicrobials, representing a prevalence of 64%. A total of 144 antimicrobial prescriptions were prescribed in 87 patients. The majority of the antimicrobials were administered parenterally (n=122, 84.7%), and over 60% (n=53) of the patients on antimicrobials received two antimicrobials. The majority of antimicrobials used for therapy were empiric in nature (n=68, 89.5%). Over half of the patients receiving antimicrobials for surgical prophylaxis were prescribed antimicrobials for two or more days. More than 60% of the antimicrobial orders were adherent to the hospital guidelines. Conclusion: The point prevalence of the use of antimicrobials is high, which highlights the need for more efficient and targeted stewardship efforts in improving adherence with the hospital guidelines. Wide usage of broad-spectrum antimicrobials is observed.

KEYWORDS

• Antimicrobial Stewardship
• United Arab Emirates
• Tertiary-level Care
• Pilot study

Showing references and in-text citations exactly as published.

• DOI10.18549/PharmPract.2024.4.3071Copy

RELATED ARTICLES

Matched on section and article type within this issue of PP.

• Article · VOLUME 22, ISSUE 4Assessment of Jordanian Pharmacists' Knowledge and Awareness of Liraglutide Injection and their Practice in Counseling Obesity PatientsJumanah D. Al-Shawabkeh · pp. 1–13Original ResearchSame type: Article
• Article · VOLUME 22, ISSUE 4Evaluating the management of urinary tract infections by community pharmacists in Queensland, AustraliaJean M Spinks, Esther TL Lau, Beverley D Glass, Lisa M Nissen · pp. 1–10Original ResearchSame type: Article
• Article · VOLUME 22, ISSUE 4Association between Toll-Like Receptor 4 Gene and inflammatory bowel disease among Jordanian patientsMalek Zihlif, Zainab Zakaraya, Rawan Nael, Abed Al-Rahman Al-Shudiefat, Mohammad Alshhab, Ahmad Sundookah, Ahmad R. Alsayed · pp. 1–7Original ResearchSame type: Article
• Article · VOLUME 22, ISSUE 4The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in LibyaAsmaa S.H. Alhomri, Ahmed A. Battah, Ahmed A. Elberry, Eman K.A. Abdelall, Raghda R.S. Hussein · pp. 1–13Original ResearchSame type: Article